SEARCH

SEARCH BY CITATION

References

  • Adinolfi L.E., Gambardella M., Andreana A., Tripodi M.F., Utili R., Ruggiero G. (2001) Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 33, 13581364.
  • Ahima R.S., Saper C.B., Flier J.S., Elmquist J.K. (2000) Leptin regulation of neuroendocrine systems. Front Neuroendocrinol. 21, 263307.
  • Almind K., Doria A., Kahn C.R. (2001) Putting the genes for type II diabetes on the map. Nat. Med. 7, 277279.
  • Angulo P. & Lindor K.D. (2002) Treatment of non-alcoholic steatohepatitis. Best Pract. Res. Clin. Gastroenterol. 16, 797810.
  • Anstee Q.M., Wright M., Goldin R. et al. (2003) A Novel murine model of non-alcoholic steatohepatitis generated using a sensitised ENU mutagenesis screen. Hepatology Supplement 1, 469A.
  • Aoyama T., Peters J.M., Iritani N. et al. (1998) Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J. Biol. Chem. 273, 56785684.
  • Araya J., Rodrigo R., Videla L.A. et al. (2004) Increase in long-chain polyunsaturated fatty acid n – 6/n – 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clin. Sci. (Lond.) 106, 635643.
  • Berriot-Varoqueaux N., Aggerbeck L.P., Samson-Bouma M., Wetterau J.R. (2000) The role of the microsomal triglygeride transfer protein in abetalipoproteinemia. Annu. Rev. Nutr. 20, 663697.
  • Biddinger S.B., Almind K., Miyazaki M., Kokkotou E., Ntambi J.M., Kahn C.R. (2005) Effects of diet and genetic background on sterol regulatory element-binding protein-1c, stearoyl-CoA desaturase 1, and the development of the metabolic syndrome. Diabetes 54, 13141323.
  • Bleisch V.R., Mayer J., Dickie M.M. (1952) Familial diabetes mellitus in mice, associated with insulin resistance, obesity, and hyperplasia of the islands of langerhans. Am. J. Pathol. 28, 369385.
  • Bradbury M.W. & Berk P.D. (2004) Lipid metabolism in hepatic steatosis. Clin. Liver Dis. 8, 639671, xi.
  • Brix A.E., Elgavish A., Nagy T.R., Gower B.A., Rhead W.J., Wood P.A. (2002) Evaluation of liver fatty acid oxidation in the leptin-deficient obese mouse. Mol. Genet. Metab 75, 219226.
  • Browning J.D. & Horton J.D. (2004) Molecular mediators of hepatic steatosis and liver injury. J. Clin. Invest 114, 147152.
  • Brunt E.M. (2004) Nonalcoholic steatohepatitis. Semin. Liver Dis. 24, 320.
  • Caldwell S.H., Oelsner D.H., Iezzoni J.C., Hespenheide E.E., Battle E.H., Driscoll C.J. (1999) Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 29, 664669.
  • Carvalho E., Jansson P.A., Nagaev I., Wenthzel A.M., Smith U. (2001) Insulin resistance with low cellular IRS-1 expression is also associated with low GLUT4 expression and impaired insulin- stimulated glucose transport. FASEB J. 15, 11011103.
  • Chalasani N., Crabb D.W., Cummings O.W. et al. (2003) Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis? Am. J. Gastroenterol. 98, 27712776.
    Direct Link:
  • Chavin K.D., Yang S., Lin H.Z. et al. (1999) Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J. Biol. Chem. 274, 56925700.
  • Chawla R.K., Watson W.H., Eastin C.E., Lee E.Y., Schmidt J., McClain C.J. (1998) S-adenosylmethionine deficiency and TNF-alpha in lipopolysaccharide-induced hepatic injury. Am. J. Physiol. 275, G125G129.
  • Chen H., Charlat O., Tartaglia L.A. et al. (1996) Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84, 491495.
  • Coburn C.T., Knapp F.F. Jr, Febbraio M., Beets A.L., Silverstein R.L., Abumrad N.A. (2000) Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J. Biol. Chem. 275, 3252332529.
  • Coleman D.L. (1973) Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 9, 294298.
  • Coleman D.L. (1978) Obese and diabetes: two mutant genes causing diabetes–obesity syndromes in mice. Diabetologia 14, 141148.
  • Collins S., Martin T.L., Surwit R.S., Robidoux J. (2004) Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiol. Behav. 81, 243248.
  • Crespo J., Cayon A., Fernandez-Gil P. et al. (2001) Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 34, 11581163.
  • Day C.P. (2002) Pathogensis of steatohepatitis. Best. Pract. Res. Clin. Gastroenterol. 16, 663678.
  • Day C.P. & James O.F. (1998) Steatohepatitis: a tale of two ‘hits’? Gastroenterology 114, 842845.
  • Deng Q.G., She H., Cheng J.H. et al. (2005) Steatohepatitis induced by intragastric overfeeding in mice. Hepatology 42, 905914.
  • Dentin R., Girard J., Postic C. (2005) Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver. Biochimie 87, 8186.
  • Dragani T.A. (ed.) (1998) Human Polygenic Diseases: Animal Models. Australia: Harwood.
  • Edvardsson U., Von Lowenhielm H.B., Panfilov O., Nystrom A.C., Nilsson F., Dahllof B. (2003) Hepatic protein expression of lean mice and obese diabetic mice treated with peroxisome proliferator-activated receptor activators. Proteomics. 3, 468478.
  • Enriquez A., Leclercq I., Farrell G.C., Robertson G. (1999) Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob/ob mice, and fa/fa Zucker rats. Biochem. Biophys. Res. Commun. 255, 300306.
  • Faggioni R., Fantuzzi G., Gabay C. et al. (1999) Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am. J. Physiol. 276, R136R142.
  • Fantuzzi G. & Faggioni R. (2000) Leptin in the regulation of immunity, inflammation, and hematopoiesis. J. Leukoc. Biol. 68, 437446.
  • Feldstein A.E., Canbay A., Guicciardi M.E., Higuchi H., Bronk S.F., Gores G.J. (2003) Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice. J. Hepatol. 39, 978983.
  • Fletcher L.M., Bridle K.R., Crawford D.H. (2003) Effect of alcohol on iron storage diseases of the liver. Best Pract. Res. Clin. Gastroenterol. 17, 663677.
  • Friedman S.L. (2003) Liver fibrosis – from bench to bedside. J. Hepatol. 38 (Suppl. 1), S38S53.
  • Friedman J.M., Leibel R.L., Siegel D.S., Walsh J., Bahary N. (1991) Molecular mapping of the mouse ob mutation. Genomics 11, 10541062.
  • Gao D., Wei C., Chen L., Huang J., Yang S., Diehl A.M. (2004) Oxidative DNA damage and DNA repair enzyme expression are inversely related in murine models of fatty liver disease. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G1070G1077.
  • George J., Pera N., Phung N., Leclercq I., Yun Hou J., Farrell G. (2003) Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis. J. Hepatol. 39, 756764.
  • Ghilardi N., Ziegler S., Wiestner A., Stoffel R., Heim M.H., Skoda R.C. (1996) Defective STAT signaling by the leptin receptor in diabetic mice. Proc. Natl. Acad. Sci. U.S.A 93, 62316235.
  • Goudriaan J.R., Dahlmans V.E., Teusink B. et al. (2003) CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice. J. Lipid Res. 44, 22702277.
  • Grubb S.C., Churchill G.A., Bogue M.A. (2004) A collaborative database of inbred mouse strain characteristics. Bioinformatics. 20, 28572859.
  • Guebre-Xabier M., Yang S., Lin H.Z., Schwenk R., Krzych U., Diehl A.M. (2000) Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage. Hepatology 31, 633640.
  • Honda H., Ikejima K., Hirose M. et al. (2002) Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver. Hepatology 36, 1221.
  • Hourigan L.F., Macdonald G.A., Purdie D. et al. (1999) Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 29, 12151219.
  • Hu K.Q., Kyulo N.L., Esrailian E. et al. (2004) Overweight and obesity, hepatic steatosis, and progression of chronic hepatitis C: a retrospective study on a large cohort of patients in the United States. J. Hepatol. 40, 147154.
  • Hummel K.P., Dickie M.M., Coleman D.L. (1966) Diabetes, a new mutation in the mouse. Science 153, 11271128.
  • Ibdah J.A., Paul H., Zhao Y. et al. (2001) Lack of mitochondrial trifunctional protein in mice causes neonatal hypoglycemia and sudden death. J. Clin. Invest 107, 14031409.
  • Ibdah J.A., Perlegas P., Zhao Y. et al. (2005) Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance. Gastroenterology 128, 13811390.
  • Iizuka K., Bruick R.K., Liang G., Horton J.D., Uyeda K. (2004) Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. Proc. Natl. Acad. Sci. U.S.A. 101, 72817286.
  • Ingalls A.M., Dickie M.M., Snell G.D. (1950) Obese, a new mutation in the house mouse. J. Hered. 41, 317318.
  • Jones D.E. (2005) Fat is an immuno-regulatory issue. Hepatology 42, 755758.
  • Kahn C.R. (1994) Banting Lecture: Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43, 10661084.
  • Kashireddy P.V. & Rao M.S. (2004) Lack of peroxisome proliferator-activated receptor alpha in mice enhances methionine and choline deficient diet-induced steatohepatitis. Hepatol. Res. 30, 104110.
  • Kersten S., Seydoux J., Peters J.M., Gonzalez F.J., Desvergne B., Wahli W. (1999) Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J. Clin. Invest 103, 14891498.
  • Kirsch R., Clarkson V., Shephard E.G. et al. (2003) Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies. J. Gastroenterol. Hepatol. 18, 12721282.
  • Kleiner D.E., Brunt E.M., Van Natta M. et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 13131321.
  • Koppe S.W., Sahai A., Malladi P., Whitington P.F., Green R.M. (2004) Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet. J. Hepatol. 41, 592598.
  • Koteish A. & Diehl A.M. (2001) Animal models of steatosis. Semin. Liver Dis. 21, 89104.
  • Koteish A. & Mae D.A. (2002) Animal models of steatohepatitis. Best. Pract. Res. Clin. Gastroenterol. 16, 679690.
  • Kugelmas M., Hill D.B., Vivian B., Marsano L., Mcclain C.J. (2003) Cytokines and Nash: a pilot study of the effects of lifestyle modification and vitamin E. Hepatology 38, 413419.
  • Kulinski A., Vance D.E., Vance J.E. (2004) A choline-deficient diet in mice inhibits neither the CDP-choline pathway for phosphatidylcholine synthesis in hepatocytes nor apolipoprotein B secretion. J. Biol. Chem. 279, 2391623924.
  • Kuwajima M., Kono N., Horiuchi M. et al. (1991) Animal model of systemic carnitine deficiency: analysis in C3H-H-2 degrees strain of mouse associated with juvenile visceral steatosis. Biochem. Biophys. Res. Commun. 174, 10901094.
  • Leclercq I.A., Farrell G.C., Schriemer R., Robertson G.R. (2002) Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J. Hepatol. 37, 206213.
  • Leclercq I.A., Field J., Farrell G.C. (2003) Leptin-specific mechanisms for impaired liver regeneration in ob/ob mice after toxic injury. Gastroenterology 124, 14511464.
  • Letteron P., Sutton A., Mansouri A., Fromenty B., Pessayre D. (2003) Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice. Hepatology 38, 133140.
  • Li Z., Oben J.A., Yang S. et al. (2004) Norepinephrine regulates hepatic innate immune system in leptin-deficient mice with nonalcoholic steatohepatitis. Hepatology 40, 434441.
  • Li Z., Soloski M.J., Diehl A.M. (2005) Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Hepatology 42, 880885.
  • Ludwig J., Viggiano T.R., Mcgill D.B., Oh B.J. (1980) Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin. Proc. 55, 434438.
  • Marchesini G., Brizi M., Morselli-Labate A.M. et al. (1999) Association of nonalcoholic fatty liver disease with insulin resistance. Am. J. Med. 107, 450455.
  • Marchesini G., Bugianesi E., Forlani G. et al. (2003) Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37, 917923.
  • Matteoni C.A., Younossi Z.M., Gramlich T., Boparai N., Liu Y.C., McCullough A.J. (1999) Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116, 14131419.
  • Mayer J., Bates M.W., Dickie M.M. (1951) Hereditary diabetes in genetically obese mice. Science 113, 746747.
  • Mayer J., Dickie M.M., Bates M.W., Vitale J.J. (1951) Free selection of nutrients by hereditarily obese mice. Science 113, 745746.
  • McClain C.J., Mokshagundam S.P., Barve S.S. et al. (2004) Mechanisms of non-alcoholic steatohepatitis. Alcohol 34, 6779.
  • Mcgarry J.D. (2002) Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51, 718.
  • Mcgarry J.D., Mannaerts G.P., Foster D.W. (1977) A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis. J. Clin. Invest 60, 265270.
  • Memon R.A., Feingold K.R., Moser A.H., Fuller J., Grunfeld C. (1998) Regulation of fatty acid transport protein and fatty acid translocase mRNA levels by endotoxin and cytokines. Am. J. Physiol. 274, E210E217.
  • Oben J.A., Roskams T., Yang S. et al. (2003) Norepinephrine induces hepatic fibrogenesis in leptin deficient ob/ob mice. Biochem. Biophys. Res. Commun. 308, 284292.
  • Pessayre D., Berson A., Fromenty B., Mansouri A. (2001) Mitochondria in steatohepatitis. Semin. Liver Dis. 21, 5769.
  • Pessayre D., Mansouri A., Fromenty B. (2002) Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 282, G193G199.
  • Poonawala A., Nair S.P., Thuluvath P.J. (2000) Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 32, 689692.
  • Powell E.E., Cooksley W.G., Hanson R., Searle J., Halliday J.W., Powell L.W. (1990) The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 11, 7480.
  • Poynard T., Bedossa P., Opolon P. (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349, 825832.
  • Rao M.S. & Reddy J.K. (2001) Peroxisomal beta-oxidation and steatohepatitis. Semin. Liver Dis. 21, 4355.
  • Ratziu V., Giral P., Charlotte F. et al. (2000) Liver fibrosis in overweight patients. Gastroenterology 118, 11171123.
  • Reddy J.K. (2001) Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 281, G1333G1339.
  • Reeves H.L., Burt A.D., Wood S., Day C.P. (1996) Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis. J. Hepatol. 25, 677683.
  • Reid A.E. (2001) Nonalcoholic steatohepatitis. Gastroenterology 121, 710723.
  • Rinella M.E. & Green R.M. (2004) The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance. J. Hepatol. 40, 4751.
  • Sahai A., Malladi P., Green R.M., Whitington P.F. (2003) Steatohepatitis and liver fibrosis associated with upregulated osteopontin expression in diabetic/insulin-resistant db/db mice fed a methionine and choline deficient diet. Hepatology 38, 497A.
  • Sanyal A.J. (2002) AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123, 17051725.
  • Sanyal A.J., Campbell-Sargent C., Mirshahi F. et al. (2001) Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120, 11831192.
  • Schattenberg J.M., Wang Y., Singh R., Rigoli R.M., Czaja M.J. (2005) Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling. J. Biol. Chem. 280, 98879894.
  • Shimano H., Horton J.D., Hammer R.E., Shimomura I., Brown M.S., Goldstein J.L. (1996) Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J. Clin. Invest 98, 15751584.
  • Shimomura I., Bashmakov Y., Horton J.D. (1999) Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J. Biol. Chem. 274, 3002830032.
  • Shimomura I., Hammer R.E., Richardson J.A. et al. (1998) Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev. 12, 31823194.
  • Shimomura I., Shimano H., Korn B.S., Bashmakov Y., Horton J.D. (1998) Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver. J. Biol. Chem. 273, 3529935306.
  • Shoelson S.E., Lee J., Yuan M. (2003) Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int. J. Obes. Relat Metab Disord. 27 (Suppl. 3), S49S52.
  • Silver L.M. (1995) Mouse Genetics: Concepts and Applications. New York, Oxford: Oxford University Press.
  • Skelly M.M., James P.D., Ryder S.D. (2001) Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. J. Hepatol. 35, 195199.
  • Sundaram S.S., Whitington P.F., Green R.M. (2005) Steatohepatitis develops rapidly in transgenic mice overexpressing Abcb11 and fed a methionine-choline-deficient diet. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G1321G1327.
  • Tartaglia L.A., Dembski M., Weng X. et al. (1995) Identification and expression cloning of a leptin receptor, OB-R. Cell 83, 12631271.
  • Teli M.R., Day C.P., Burt A.D., Bennett M.K., James O.F. (1995) Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 346, 987990.
  • Tilg H. & Diehl A.M. (2000) Cytokines in alcoholic and nonalcoholic steatohepatitis. N. Engl. J. Med. 343, 14671476.
  • Tous M., Ferre N., Camps J., Riu F., Joven J. (2005) Feeding apolipoprotein E-knockout mice with cholesterol and fat enriched diets may be a model of non-alcoholic steatohepatitis. Mol. Cell Biochem. 268, 5358.
  • Toye A.A., Lippiat J.D., Proks P. et al. (2005) A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice. Diabetologia 48, 675686.
  • Uysal K.T., Wiesbrock S.M., Marino M.W., Hotamisligil G.S. (1997) Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389, 610614.
  • Voshol P.J., Haemmerle G., Ouwens D.M. et al. (2003) Increased hepatic insulin sensitivity together with decreased hepatic triglyceride stores in hormone-sensitive lipase-deficient mice. Endocrinology 144, 34563462.
  • Voshol P.J., Jong M.C., Dahlmans V.E. et al. (2001) In muscle-specific lipoprotein lipase-overexpressing mice, muscle triglyceride content is increased without inhibition of insulin-stimulated whole-body and muscle-specific glucose uptake. Diabetes 50, 25852590.
  • Wanless I.R. & Lentz J.S. (1990) Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 12, 11061110.
  • Weltman M.D., Farrell G.C., Hall P., Ingelman-Sundberg M., Liddle C. (1998) Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology 27, 128133.
  • Weltman M.D., Farrell G.C., Liddle C. (1996) Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 111, 16451653.
  • West D.B., Boozer C.N., Moody D.L., Atkinson R.L. (1992) Dietary obesity in nine inbred mouse strains. Am. J. Physiol. 262, R1025R1032.
  • Wetterau J.R., Aggerbeck L.P., Bouma M.E. et al. (1992) Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science 258, 9991001.
  • Winzell M.S. & Ahren B. (2004) The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 53 (Suppl. 3), S215S219.
  • Yamashita H., Takenoshita M., Sakurai M. et al. (2001) A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc. Natl. Acad. Sci. U.S.A 98, 91169121.
  • Yang S.Q., Lin H.Z., Lane M.D., Clemens M., Diehl A.M. (1997) Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc. Natl. Acad. Sci. U.S.A 94, 25572562.
  • Yao Z.M. & Vance D.E. (1990) Reduction in VLDL, but not HDL, in plasma of rats deficient in choline. Biochem. Cell Biol. 68, 552558.
  • Yoshimatsu M., Terasaki Y., Sakashita N. et al. (2004) Induction of macrophage scavenger receptor MARCO in nonalcoholic steatohepatitis indicates possible involvement of endotoxin in its pathogenic process. Int. J. Exp. Pathol. 85, 335343.
  • Yuan M., Konstantopoulos N., Lee J. et al. (2001) Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293, 16731677.
  • Zeisel S.H. & Blusztajn J.K. (1994) Choline and human nutrition. Annu. Rev. Nutr. 14, 269296.
  • Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425432.